Breaking News - The Fly

Open Search

PCRX

Pacira

$

()

Pacira granted RMAT designation for PCRX-201

PCRX

3/13/2024 - 07:24am

Pacira assumed with an Overweight at JPMorgan

PCRX

3/7/2024 - 04:50am

Pacira price target lowered by $10 at Barclays, here's why

PCRX

3/3/2024 - 12:27pm

Pacira reports Q4 EPS 89c, consensus 88c

PCRX

2/29/2024 - 08:04am

Pacira announces publication of study of EXPAREL

PCRX

2/15/2024 - 08:39am

Pacira awarded Brand Pharmaceuticals agreement with Premier

PCRX

2/7/2024 - 08:16am

Pacira named a top pick for 2024 at H.C. Wainwright

PCRX

1/26/2024 - 06:06am

Pacira reports preliminary FY23 revenue $675M, consensus $677.3M

PCRX

1/4/2024 - 17:02pm

Pacira appoints Frank Lee as CEO

PCRX

12/21/2023 - 07:34am

Pacira initiated with bullish view at Raymond James, here's why

PCRX

12/20/2023 - 05:22am

Pacira consensus for 2024 looks too high, 2025 too low, says Jefferies

PCRX

11/28/2023 - 07:48am

Pacira announces FDA approval of expanded EXPAREL label

PCRX

11/10/2023 - 07:31am

Pacira price target lowered to $50 from $57 at Barclays

PCRX

11/7/2023 - 05:50am

Pacira price target lowered to $57 from $63 at H.C. Wainwright

PCRX

11/6/2023 - 06:07am

Pacira price target lowered to $58 from $67 at RBC Capital

PCRX

11/3/2023 - 08:31am